(Q51286288)

2 April 2018

title

Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity. (English)

1 reference

2 April 2018

0 references

1 reference

Weiping Sun

1

0 references

author name string

Chunping Zeng

2

1 reference

2 April 2018

Lizhen Liao

3

1 reference

2 April 2018

Juan Chen

4

1 reference

2 April 2018

Ying Wang

5

1 reference

2 April 2018

language of work or name

English

0 references

publication date

7 April 2016

1 reference

2 April 2018

Current Medical Research and Opinion

published in

1 reference

2 April 2018

volume

32

1 reference

2 April 2018

issue

8

1 reference

2 April 2018

page(s)

1389-1396

1 reference

2 April 2018

Weight loss and mortality in type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Efficacy of metformin in the treatment of NIDDM. Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Postprandial hyperglycaemia and vascular damage--the benefits of acarbose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Effects of acarbose on the acceleration of postprandial hyperglycemia-induced pathological changes induced by intermittent hypoxia in lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Postprandial hyperglycemia and glycemic variability: should we care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Who should benefit from the use of alpha-glucosidase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Postprandial glucose regulation: new data and new implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

GLP-1 based therapeutics: simultaneously combating T2DM and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

The role of dysregulated glucagon secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Insulin signaling in alpha cells modulates glucagon secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

The role of oxidative stress in the pathogenesis of diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03007995.2016.1176013

10.1080/03007995.2016.1176013

21 January 2018

Identifiers

DOI

1 reference

2 April 2018

PubMed ID

27052634

1 reference

2 April 2018